Back to search

Article

Anti-Cancer Outcome of Glucocorticoid Receptor Transrepression by Synephrine Derivatives

2025-10-24

Abstract excerpt

<h4>Background: </h4> /Objectives: Glucocorticoids (GCs) present effective anti-cancer drugs for the treatment of hematological malignancies but their clinical use is limited due to their multiple adverse effects. Selective glucocorticoid receptor agonists/modulators (SEGRAMs) modify glucocorticoid receptor (GR) function shifting it towards therapeutically important transrepression and, therefore, could be safer a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
54003f0c-0714-520d-a5e6-fd9e8fd13371
DOI
10.20944/preprints202510.1879.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Anti-Cancer Outcome of Glucocorticoid Receptor Transrepression by Synephrine DerivativesDOI 10.20944/preprints202510.1879.v1
Select a neighboring publication to make it the new centre.